<p>MDB Capital Holdings, LLC A 类股（(MDBH)）已召开第三季度财报电话会议。请继续阅读会议的主要亮点。</p>
<h3>TipRanks 黑色星期五促销</h3>
<ul>
<li>享受 TipRanks Premium 60% 的折扣，获取您投资所需的数据支持洞察和研究工具。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据 - 现在也享受 60% 的折扣。</li>
</ul>
<p>在最近的财报电话会议上，MDB Capital Holdings, LLC A 类股对其当前财务状况和未来前景表达了复杂的情绪。公司自豪地展示了其在首次公开募股（IPO）和扩展运营方面的成功记录，这为未来的增长奠定了良好的基础。然而，股票价格下跌和微型资本市场的严峻挑战也被提及。尽管其管道中的积极进展和即将推出的项目令人鼓舞，但运营费用和关键项目的延误抑制了整体乐观情绪。</p>
<h2>成功的 IPO 记录</h2>
<p>MDB Capital Holdings 在过去 28 年中拥有令人称道的成功 IPO 历史。值得一提的是，他们所有的 IPO 在上市后某个时刻都以两倍于 IPO 价格交易，展示了公司为投资者创造显著价值的能力。</p>
<h2>深厚的机会管道</h2>
<p>公司目前正在与四到五家公司进行谈判，计划明年推出三到五个新项目。这一强劲的管道表明 MDB 继续致力于扩展其投资组合并抓住新的市场机会。</p>
<h2>eXoZymes 和 HeartBeam 的进展</h2>
<p>eXoZymes 的激动人心的发展即将到来，预计将彻底改变制药开发，而 HeartBeam 则接近 FDA 批准一款突破性的 12 导联心电图设备。这些创新可能显著提升 MDB 的市场地位。</p>
<h2>扩大运营规模</h2>
<p>MDB Capital Holdings 专注于扩大其运营，以支持每年推出三到五家公司。这一战略得到了经过验证的运营框架的支持，使公司能够实现持续增长。</p>
<h2>PatentVest 的潜在分拆</h2>
<p>计划正在进行中，可能会将 PatentVest 分拆，成为美国首家专注于专利法的上市律师事务所。这一举措可能会开辟新的收入来源，并增强 MDB 的市场影响力。</p>
<h2>股票价格下跌</h2>
<p>尽管取得了成功，MDB Capital Holdings 的股票价格却面临显著下跌，交易价格低于市场价值，尽管其股权头寸超过市场价值。这一差异突显了投资者的担忧和市场波动性。</p>
<h2>微型资本市场挑战</h2>
<p>微型资本市场依然充满挑战，投资者对 MDB 持续挑选成功项目的能力表示担忧。这一市场环境对公司的增长战略构成风险。</p>
<h2>运营费用</h2>
<p>运营费用仍然是一个问题，前三个季度使用了 590 万美元。这些成本尚未完全通过融资活动抵消，影响了公司的财务健康。</p>
<h2>eXoZymes 和 Paulex Bio 的延误</h2>
<p>在变现 eXoZymes 和将 Paulex Bio 推向市场方面的延误已被注意到，影响了预期的时间表，并可能影响未来的收入来源。</p>
<h2>前瞻性指导</h2>
<p>展望未来，MDB Capital Holdings 计划通过将每年公开风险投资的推出数量从每 18 个月一次增加到每年三到五次来扩大运营。首席执行官 Chris Marlett 强调了公司通过融资活动覆盖 1000 万美元运营费用的战略，同时保持在已推出公司的显著股权头寸。Marlett 对微型资本市场的潜在复苏以及 MDB 通过策划行业领先公司实现不对称回报的能力表示乐观。</p>
<p>总之，MDB Capital Holdings 的财报电话会议揭示了一家拥有强大记录和有前景管道的公司，但在当前市场环境中面临重大挑战。尽管运营费用和项目延误构成障碍，但公司的战略计划和创新发展为未来的增长和成功提供了希望。</p>

BEAT

MDBH

EXOZ

<p>MDB Capital Holdings, LLC A 类股（MDBH）举行了第三季度财报电话会议，透露了混合的财务前景。该公司在首次公开募股方面有着强劲的业绩记录，并且拥有有前景的项目管道，包括 eXoZymes 和 HeartBeam 的开发。然而，面临的挑战包括股价下跌、微型股市场的艰难、高昂的运营费用以及项目延迟。会议中讨论了扩大运营和剥离 PatentVest 的计划。尽管当前面临困难，首席执行官 Chris Marlett 对未来的增长仍持乐观态度</p>

<p>MDB Capital Holdings, LLC Class A ((MDBH)) has held its Q3 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>MDB Capital Holdings, LLC A 类股（(MDBH)）已召开第三季度财报电话会议。请继续阅读会议的主要亮点。</p>
</div><h3>TipRanks Black Friday Sale</h3>
<div class="lb-trans"><h3>TipRanks 黑色星期五促销</h3>
</div><ul>
<li>Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.</li>
<li>Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio -  now also 60% off</li>
</ul>
<div class="lb-trans"><ul>
<li>享受 TipRanks Premium 60% 的折扣，获取您投资所需的数据支持洞察和研究工具。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据 - 现在也享受 60% 的折扣。</li>
</ul>
</div><p>During the recent earnings call, MDB Capital Holdings, LLC Class A expressed a mixed sentiment regarding its current financial standing and future prospects. The company boasted a successful track record in launching IPOs and scaling operations, which bodes well for future growth. However, challenges such as a declining stock price and a tough microcap market were also highlighted. Despite positive developments in their pipeline and upcoming launches, operational expenses and delays in key projects have tempered the overall optimism.</p>
<div class="lb-trans"><p>在最近的财报电话会议上，MDB Capital Holdings, LLC A 类股对其当前财务状况和未来前景表达了复杂的情绪。公司自豪地展示了其在首次公开募股（IPO）和扩展运营方面的成功记录，这为未来的增长奠定了良好的基础。然而，股票价格下跌和微型资本市场的严峻挑战也被提及。尽管其管道中的积极进展和即将推出的项目令人鼓舞，但运营费用和关键项目的延误抑制了整体乐观情绪。</p>
</div><h2>Successful IPO Track Record</h2>
<div class="lb-trans"><h2>成功的 IPO 记录</h2>
</div><p>MDB Capital Holdings has a commendable history of launching successful IPOs over the past 28 years. Impressively, all of their IPOs have traded at twice the IPO price at some point post-launch, showcasing the company’s ability to create significant value for investors.</p>
<div class="lb-trans"><p>MDB Capital Holdings 在过去 28 年中拥有令人称道的成功 IPO 历史。值得一提的是，他们所有的 IPO 在上市后某个时刻都以两倍于 IPO 价格交易，展示了公司为投资者创造显著价值的能力。</p>
</div><h2>Deep Pipeline of Opportunities</h2>
<div class="lb-trans"><h2>深厚的机会管道</h2>
</div><p>The company is currently negotiating with four to five companies in late stages, aiming to launch three to five new ventures next year. This robust pipeline indicates MDB’s continued commitment to expanding its portfolio and seizing new market opportunities.</p>
<div class="lb-trans"><p>公司目前正在与四到五家公司进行谈判，计划明年推出三到五个新项目。这一强劲的管道表明 MDB 继续致力于扩展其投资组合并抓住新的市场机会。</p>
</div><h2>eXoZymes and HeartBeam Developments</h2>
<div class="lb-trans"><h2>eXoZymes 和 HeartBeam 的进展</h2>
</div><p>Exciting developments are on the horizon with eXoZymes, which is expected to revolutionize pharmaceutical development, and HeartBeam, which is nearing FDA approval for a groundbreaking 12-lead ECG device. These innovations could significantly enhance MDB’s market position.</p>
<div class="lb-trans"><p>eXoZymes 的激动人心的发展即将到来，预计将彻底改变制药开发，而 HeartBeam 则接近 FDA 批准一款突破性的 12 导联心电图设备。这些创新可能显著提升 MDB 的市场地位。</p>
</div><h2>Scaling Operations</h2>
<div class="lb-trans"><h2>扩大运营规模</h2>
</div><p>MDB Capital Holdings is focused on scaling its operations to support the launch of three to five companies annually. This strategy is backed by a proven operational framework, positioning the company for sustained growth.</p>
<div class="lb-trans"><p>MDB Capital Holdings 专注于扩大其运营，以支持每年推出三到五家公司。这一战略得到了经过验证的运营框架的支持，使公司能够实现持续增长。</p>
</div><h2>Potential Spinout of PatentVest</h2>
<div class="lb-trans"><h2>PatentVest 的潜在分拆</h2>
</div><p>Plans are underway to spin out PatentVest, potentially becoming the first public law firm in the U.S. focused on patent law. This move could open new revenue streams and enhance MDB’s market presence.</p>
<div class="lb-trans"><p>计划正在进行中，可能会将 PatentVest 分拆，成为美国首家专注于专利法的上市律师事务所。这一举措可能会开辟新的收入来源，并增强 MDB 的市场影响力。</p>
</div><h2>Stock Price Decline</h2>
<div class="lb-trans"><h2>股票价格下跌</h2>
</div><p>Despite its successes, MDB Capital Holdings has faced a significant decline in its stock price, trading at a discount even though its equity positions exceed market value. This discrepancy highlights investor concerns and market volatility.</p>
<div class="lb-trans"><p>尽管取得了成功，MDB Capital Holdings 的股票价格却面临显著下跌，交易价格低于市场价值，尽管其股权头寸超过市场价值。这一差异突显了投资者的担忧和市场波动性。</p>
</div><h2>Microcap Market Challenges</h2>
<div class="lb-trans"><h2>微型资本市场挑战</h2>
</div><p>The microcap market remains challenging, with concerns about MDB’s ability to consistently pick successful ventures. This market environment poses risks to the company’s growth strategy.</p>
<div class="lb-trans"><p>微型资本市场依然充满挑战，投资者对 MDB 持续挑选成功项目的能力表示担忧。这一市场环境对公司的增长战略构成风险。</p>
</div><h2>Operational Expenses</h2>
<div class="lb-trans"><h2>运营费用</h2>
</div><p>Operating expenses remain a concern, with $5.9 million used in the first three quarters. These costs have not yet been fully offset by financing activities, impacting the company’s financial health.</p>
<div class="lb-trans"><p>运营费用仍然是一个问题，前三个季度使用了 590 万美元。这些成本尚未完全通过融资活动抵消，影响了公司的财务健康。</p>
</div><h2>Delays in eXoZymes and Paulex Bio</h2>
<div class="lb-trans"><h2>eXoZymes 和 Paulex Bio 的延误</h2>
</div><p>Delays in monetizing eXoZymes and bringing Paulex Bio to market have been noted, affecting anticipated timelines and potentially impacting future revenue streams.</p>
<div class="lb-trans"><p>在变现 eXoZymes 和将 Paulex Bio 推向市场方面的延误已被注意到，影响了预期的时间表，并可能影响未来的收入来源。</p>
</div><h2>Forward-Looking Guidance</h2>
<div class="lb-trans"><h2>前瞻性指导</h2>
</div><p>Looking ahead, MDB Capital Holdings plans to scale operations by increasing the number of annual public venture launches from one every 18 months to three to five per year. CEO Chris Marlett emphasized the company’s strategy to cover its $10 million operating expenses through financing activities while maintaining significant equity positions in launched companies. Marlett expressed optimism about the potential resurgence of the microcap market and MDB’s ability to deliver asymmetric returns by curating category-leading companies.</p>
<div class="lb-trans"><p>展望未来，MDB Capital Holdings 计划通过将每年公开风险投资的推出数量从每 18 个月一次增加到每年三到五次来扩大运营。首席执行官 Chris Marlett 强调了公司通过融资活动覆盖 1000 万美元运营费用的战略，同时保持在已推出公司的显著股权头寸。Marlett 对微型资本市场的潜在复苏以及 MDB 通过策划行业领先公司实现不对称回报的能力表示乐观。</p>
</div><p>In summary, MDB Capital Holdings’ earnings call revealed a company with a strong track record and promising pipeline, yet facing significant challenges in the current market environment. While operational expenses and project delays pose hurdles, the company’s strategic plans and innovative developments offer hope for future growth and success.</p>
<div class="lb-trans"><p>总之，MDB Capital Holdings 的财报电话会议揭示了一家拥有强大记录和有前景管道的公司，但在当前市场环境中面临重大挑战。尽管运营费用和项目延误构成障碍，但公司的战略计划和创新发展为未来的增长和成功提供了希望。</p>
</div>

MDB Capital Holdings：在增长计划中应对挑战